Feature Channels: Blood

Filters close
Newswise: RUDN Scientists on the Possibilities of Studying Single Cells in One of the Types of Childhood Leukemia
Released: 29-Nov-2023 3:05 AM EST
RUDN Scientists on the Possibilities of Studying Single Cells in One of the Types of Childhood Leukemia
Scientific Project Lomonosov

RUDN Laboratory of Biology of Single Cells studied the possibilities of DNA sequencing at the level of individual cells in patients with a rare form of childhood leukemia.

Newswise: Yale Cancer Center Experts Present New Research at Hematology Annual Meeting
Released: 28-Nov-2023 4:05 PM EST
Yale Cancer Center Experts Present New Research at Hematology Annual Meeting
Yale Cancer Center/Smilow Cancer Hospital

Physicians and scientists from Yale Cancer Center, part of Yale School of Medicine, will present new research at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego, Calif., from December 9 to 12. This year’s ASH meeting will include oral and poster presentations, workshops, and educational sessions for hematology professionals.

28-Nov-2023 11:30 AM EST
Ohio State receives $14 million to study optimal aspirin therapy in pregnancy
Ohio State University Wexner Medical Center

A research team at The Ohio State University Wexner Medical Center and College of Medicine has been approved for a $14 million award from the Patient-Centered Outcomes Research Institute (PCORI) to study whether a higher daily dose of aspirin is more effective in decreasing the risk of dangerous blood pressure complications among some pregnant people.

Newswise: St. Jude revealed functional targets of oncogenic HOXA9 in high-risk pediatric leukemia
Released: 28-Nov-2023 11:05 AM EST
St. Jude revealed functional targets of oncogenic HOXA9 in high-risk pediatric leukemia
St. Jude Children's Research Hospital

Scientists at St. Jude Children’s Research Hospital identified target genes bound and regulated by HOXA9, a protein overexpressed in high-risk leukemia, extending understanding and opening new possibilities for treatment.

Newswise: Montefiore Einstein Comprehensive Cancer Center Awarded FDA Grant for Clinical Trial on Experimental AML/MDS Treatment
Released: 28-Nov-2023 10:00 AM EST
Montefiore Einstein Comprehensive Cancer Center Awarded FDA Grant for Clinical Trial on Experimental AML/MDS Treatment
Montefiore Einstein Comprehensive Cancer Center

Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS)—two related blood diseases that disproportionally strike older adults—are notoriously difficult to treat and associated with high relapse rates.

Released: 27-Nov-2023 6:05 PM EST
Cellular postal service delivers messages from non-human cells, too
University of Connecticut

Messenger bubbles produced by human cells can pick up bacterial products and deliver them to other cells, University of Connecticut researchers report in the Nov. 16 issue of Nature Cell Biology.

   

Not for public release

This news release is embargoed until 27-Nov-2023 5:00 PM EST Released to reporters: 20-Nov-2023 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 27-Nov-2023 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 22-Nov-2023 6:05 PM EST
Cancer blood tests jumpstart diagnoses and targeted therapy
UC Davis Health

DNA fragments circulating in patients’ blood can reveal the presence of tumors long before CT scans and lead to more agile use of cancer drugs.

Newswise: Lowering a form of brain cholesterol reduces Alzheimer’s-like damage in mice
20-Nov-2023 10:05 AM EST
Lowering a form of brain cholesterol reduces Alzheimer’s-like damage in mice
Washington University in St. Louis

Researchers at Washington University School of Medicine in St. Louis have found that a form of cholesterol known as cholesteryl esters builds up in the brains of mice with Alzheimer’s-like disease, and that clearing out the cholesteryl esters helps prevent brain damage and behavioral changes.

Released: 21-Nov-2023 3:45 PM EST
It's not over until it's over. Keep up with the latest COVID research in the Coronavirus channel.
Newswise

Stay informed! Keep up with the latest research on the COVID-19 virus in the Coronavirus channel on Newswise.

Newswise: Written in Blood
16-Nov-2023 10:05 AM EST
Written in Blood
American Institute of Physics (AIP)

In Physics of Fluids, scientists demonstrate how bloodstains can yield valuable details by examining the protrusions that deviate from the boundaries of otherwise elliptical bloodstains. The researchers studied how these “tails” are formed using a series of high-speed experiments with human blood droplets less than a millimeter wide impacting horizontal surfaces at various angles. They found that the tail length can reflect information about the size, impact speed, and impact angle of the blood drop that formed the stain.

Newswise: Type 2 diabetes: a new disease mechanism uncovered
Released: 21-Nov-2023 8:05 AM EST
Type 2 diabetes: a new disease mechanism uncovered
Universite de Montreal

Published just before World Diabetes Day, work by Dr. May Faraj, director of the Research Unit on Nutrition, Lipoproteins and Cardiometabolic Diseases at the Montreal Clinical Research Institute (IRCM) and full professor at the Department of Nutrition at the University of Montreal, highlight a new mechanism and a new role for LDL – commonly called bad cholesterol – in the development of type 2 diabetes, LDL already being involved in cardiovascular diseases in the human.

Released: 20-Nov-2023 2:05 PM EST
UC Irvine-led study is first to find brain hemorrhage cause other than injured blood vessels
University of California, Irvine

Irvine, Calif., Nov. 20, 2023 — A first-of-its-kind study led by the University of California, Irvine has revealed a new culprit in the formation of brain hemorrhages that does not involve injury to the blood vessels, as previously believed. Researchers discovered that interactions between aged red blood cells and brain capillaries can lead to cerebral microbleeds, offering deeper insights into how they occur and identifying potential new therapeutic targets for treatment and prevention.

Released: 17-Nov-2023 1:05 PM EST
Discovery of hemoglobin in the epidermis sheds new light on our skin's protective properties
Elsevier

Research published in the Journal of Investigative Dermatology provides important insights into skin's defense mechanism against aging and cancer

Newswise: Fusion oncoprotein forces cell fates toward rhabdomyosarcoma
Released: 15-Nov-2023 12:05 PM EST
Fusion oncoprotein forces cell fates toward rhabdomyosarcoma
St. Jude Children's Research Hospital

Scientists at St. Jude Children’s Research Hospital showed that a fusion oncoprotein can drive molecularly indistinguishable rhabdomyosarcomas arising from both muscle and blood vessel cells.

Newswise: National Film Festival Debuts Documentary About First-of-Its-Kind Blood Cancer Master Clinical Trial
Released: 15-Nov-2023 8:05 AM EST
National Film Festival Debuts Documentary About First-of-Its-Kind Blood Cancer Master Clinical Trial
The Leukemia & Lymphoma Society (LLS)

The story of a clinical trial that is unlocking a new, personalized treatment approach with the power to save the lives of thousands of people living with an aggressive and deadly form of leukemia was screened at the American Public Health Association Film Festival this week.

Released: 15-Nov-2023 3:05 AM EST
Another step toward the HIV-1 vaccine: Dynamics of neutralizing antibodies
University of Cologne

An international team has for the first time researched the longevity of neutralizing antibodies in HIV-1-infected people. Currently, it is assumed that an HIV-1 vaccine can only be effective if it produces these antibodies in vaccinated humans.

Released: 13-Nov-2023 7:05 PM EST
New assay could revolutionize detection and treatment of acute myeloid leukemia
Elsevier

A novel assay that detects a unique molecular marker in patients with acute myeloid leukemia (AML) may revolutionize the way this disease is detected and treated according to a new report in The Journal of Molecular Diagnostics published by Elsevier.

Released: 13-Nov-2023 3:05 PM EST
Ground-breaking discovery could pave the way for new therapies to prevent cardiovascular disease and stroke
University of Leicester

Researchers at the University of Leicester have discovered the mechanism by which cholesterol in our diet is absorbed into our cells

11-Nov-2023 10:10 AM EST
Transfusing More Blood May Benefit Patients Who Have Had Heart Attack and Have Anemia
Rutgers University-New Brunswick

An international clinical trial led by physician Jeffrey L. Carson, distinguished professor of medicine at Rutgers Robert Wood Johnson Medical School, found that a liberal blood transfusion given to patients who have had a heart attack and have anemia may reduce the risk of a reoccurrence and improve survival rates.

Newswise: UTHealth Houston researchers awarded $2.6M NIH grant to study molecular pathways and potential strategies for treatment of myocardial ischemia and reperfusion injury
Released: 9-Nov-2023 4:05 PM EST
UTHealth Houston researchers awarded $2.6M NIH grant to study molecular pathways and potential strategies for treatment of myocardial ischemia and reperfusion injury
University of Texas Health Science Center at Houston

A four-year, $2.6 million grant to study circadian rhythm and novel therapies to protect the heart during a heart attack or cardiac surgery has been awarded to UTHealth Houston by the National Heart, Lung, and Blood Institute, part of the National Institutes of Health.

8-Nov-2023 4:05 PM EST
Sylvester research shows how interactions between tumor genes and microenvironment influence treatment response in multiple myeloma
Sylvester Comprehensive Cancer Center

A multicenter study led by researchers at Sylvester Comprehensive Cancer Center shows how interactions between tumor cells and immune components of the microenvironment can impact treatment responses and outcomes in patients newly diagnosed with multiple myeloma who undergo combination treatments that include targeted immunotherapy.

Newswise: S&T professor’s glass powder that controls bleeding may also prevent infections
Released: 8-Nov-2023 3:05 PM EST
S&T professor’s glass powder that controls bleeding may also prevent infections
Missouri University of Science and Technology

Scientist to collaborate with South African researcher to test glass powder for antibacterial properties.

   
Released: 8-Nov-2023 2:05 PM EST
Jana Care, Inc. Announces Initial Closing of a $6 Million Financing Round to Complete Commercialization of its Self-administered Blood Tests for Kidney and Heart Disease
Jana Care

Jana Care has secured funding to expand its at-home testing platform for chronic kidney and heart disease management.

Released: 7-Nov-2023 10:05 AM EST
Mayo Clinic Laboratories and Progentec® collaborate to bring advanced biomarker testing services to patients with autoimmune diseases
Mayo Clinic

Mayo Clinic Laboratories, a leading global reference laboratory, and Progentec Diagnostics, a digital health and biomarker technology-based company focused on autoimmune conditions, today announced a strategic collaboration to bring Progentec’s suite of proprietary biomarker blood tests for the proactive management of autoimmune diseases to market.

Released: 6-Nov-2023 6:05 PM EST
Improving the efficacy of cancer immunotherapy with modified CAR-T cells
University of Freiburg

CAR-T cell therapy is a last hope for many patients with blood, bone marrow or lymph gland cancer when other treatments such as chemotherapy are unsuccessful. A limiting factor of this otherwise very effective and safe therapy is that the cells used in the process quickly reach a state of exhaustion.

Released: 6-Nov-2023 6:05 PM EST
A blood test shows MS worsening 1 to 2 years before it happens
University of California, San Francisco (UCSF)

Multiple sclerosis patients whose blood tests reveal elevated NfL, a biomarker of nerve damage, could see worsening disability one to two years later, according to a new study spearheaded by researchers at UC San Francisco.

Released: 6-Nov-2023 4:05 PM EST
First in human trial of new drug raises hopes for patients with relapsed blood cancer
Ohio State University Wexner Medical Center

A new targeted drug, studied by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James), may offer a new treatment option for patients with blood cancers, including chronic lymphocytic leukemia and Non-Hodgkin lymphoma whose disease has stopped responding to standard treatments.

Newswise: Standing blood pressure test more accurate in detecting hypertension
Released: 6-Nov-2023 10:05 AM EST
Standing blood pressure test more accurate in detecting hypertension
UT Southwestern Medical Center

Measuring blood pressure while patients are standing rather than sitting may improve the accuracy of readings, UT Southwestern Medical Center researchers report. Their findings, published in Scientific Reports, could lead to significant improvements in early detection of high blood pressure in healthy adults.

Newswise: Some Benefits of Exercise Stem from the Immune System
1-Nov-2023 8:00 PM EDT
Some Benefits of Exercise Stem from the Immune System
Harvard Medical School

Research in mice shows that the anti-inflammatory properties of exercise may arise from immune cells mobilized to counter exercise-induced inflammation. Immune cells prevent muscle damage by lowering levels of interferon, a key driver of chronic inflammation, inflammatory diseases, and aging.

Released: 3-Nov-2023 10:05 AM EDT
An exotic tick that can kill cattle is spreading across Ohio
Ohio State University

A species of exotic tick arrived in Ohio in 2021 in such huge numbers that their feeding frenzy on a southeastern farm left three cattle dead of what researchers believe was severe blood loss.

1-Nov-2023 1:05 PM EDT
Penn Medicine Researchers Develop Gene Editing Approaches for Phenylketonuria Treatment
Perelman School of Medicine at the University of Pennsylvania

Phenylketonuria (PKU) is a rare newborn genetic disease that impacts between 1 in 10,000 to 1 in 20,000 people, depending on the individuals’ genetic ancestry. PKU causes an amino acid—called phenylalanine (Phe)—to build up in the bloodstream.

Released: 2-Nov-2023 11:05 AM EDT
Mount Sinai Researchers Receive $7 Million to Improve Outcomes for High-risk Blood Cancer Patients From the Multiple Myeloma Research Foundation
Mount Sinai Health System

The Mount Sinai Health System has received a $7 million grant from the Multiple Myeloma Research Foundation for a three-year project that aims to fast-track novel translational concepts to improve outcomes for people with high risk myeloma, the second most common blood cancer in the United States.

Newswise: Urine biomarkers can outperform serum biomarkers in certain diseases
Released: 2-Nov-2023 7:05 AM EDT
Urine biomarkers can outperform serum biomarkers in certain diseases
Chinese Academy of Sciences

Urinary biomarkers have the potential to surpass serum biomarkers in disease diagnosis and monitoring. This review highlights their non-invasive, stable, and specific nature. It explores a range of urinary biomarkers, such as proteins, genes, metabolites, electrolytes, and extracellular vesicles, showing their superiority.

Newswise: Novel exercise intervention hopes to ease pain for people with rheumatoid arthritis
Released: 1-Nov-2023 4:30 PM EDT
Novel exercise intervention hopes to ease pain for people with rheumatoid arthritis
University of South Australia

Rheumatoid arthritis is an inflammatory disease that can cause severe pain and swelling of the joints. But a novel exercise intervention could help improve physical function and quality of life in people struggling with this debilitating condition.

Newswise: Markey Cancer Center study provides valuable insights into drivers of cancer risk
Released: 1-Nov-2023 10:05 AM EDT
Markey Cancer Center study provides valuable insights into drivers of cancer risk
University of Kentucky

As people age, the DNA in their cells begins to accumulate genetic mutations. Mosaic chromosomal alterations (mCAs), a category of mutations acquired in blood cells, are linked with a 10-fold increased risk of developing blood cancer.  mCAs hold promise as a tool to identify people at high risk of developing certain cancers and diseases, but they have not yet been studied among a large, diverse cohort of people – a critical step required before such testing can be developed. University of Kentucky Markey Cancer Center researcher Yasminka A. Jakubek, Ph.D., has led the first large-scale effort to understand the co-occurrence of mCAs among individuals of diverse ancestries. The study was published in Nature Genetics Oct. 30.

Newswise: Soy expansion in Brazil linked to increase in childhood leukemia deaths
Released: 30-Oct-2023 3:00 PM EDT
Soy expansion in Brazil linked to increase in childhood leukemia deaths
College of Agricultural, Consumer and Environmental Sciences, University of Illinois Urbana-Champaign

Over the past decades, Brazil has become the world’s leading soybean producer, as well as the leading consumer of pesticides. Despite concerns about potential public health consequences, little is known about the effects of pesticide exposure in the general population.

   
25-Oct-2023 11:00 AM EDT
Intermittent fasting is safe, effective for those with Type 2 diabetes
University of Illinois Chicago

More weight lost among people who fasted, compared to calorie restriction

Released: 25-Oct-2023 3:05 PM EDT
MSU tracking adult lead levels in Michigan
Michigan State University

Adults exposed to lead at work can unintentionally bring it home, exposing their families to the highly toxic substance. While preventing lead exposure is always important, Michigan State University and other organizations are urging increased awareness during National Lead Poisoning Prevention Week, Oct. 22 to 28, designated by the U.S. Centers for Disease Control and Prevention.

Released: 25-Oct-2023 12:05 PM EDT
Post-COVID condition is not linked to ongoing infection or active brain damage
University of Gothenburg

Post COVID-19 condition does not appear to be linked to direct viral invasion of the brain or active brain damage. This has been shown by a study at the University of Gothenburg. Searching for abnormal biomarkers among the participants yielded no hits in either blood or cerebrospinal fluid samples

Released: 20-Oct-2023 5:00 PM EDT
Potato starch supplements could be solution to bone marrow transplant complications
Michigan Medicine - University of Michigan

Research shows it could potentially prevent Graft versus Host Disease from occurring.

Released: 20-Oct-2023 10:05 AM EDT
Media Advisory: Massachusetts Legislators and American College of Surgeons to Host News Conference in Support of STOP THE BLEED® Legislation
American College of Surgeons (ACS)

Representatives from the American College of Surgeons STOP THE BLEED® program, along with Massachusetts state legislators, will host a news conference on Monday, October 23, in support of recent STOP THE BLEED® legislation.

Released: 19-Oct-2023 12:05 PM EDT
Genetics influence the risk of blood clots in oral contraceptive users
Uppsala University

Women with a high genetic predisposition for blood clots are six times more likely to develop a blood clot during the first two years of using contraceptive pills according to a new study from Uppsala University. The results have been published in the American Journal of Obstetrics and Gynaecology

Released: 19-Oct-2023 10:05 AM EDT
Two probiotics identified as promising hypertension treatments
American Society for Microbiology (ASM)

Probiotics may offer a new approach to preventing and treating hypertension

Released: 18-Oct-2023 1:05 PM EDT
New method may accurately identify body fluids at crime scenes
Wiley

Identifying different types of body fluids can help forensic experts reconstruct a crime scene, but it’s difficult to do so

Newswise: UIC, Mile Square join national trial of blood test for multi-cancer screening
Released: 18-Oct-2023 10:00 AM EDT
UIC, Mile Square join national trial of blood test for multi-cancer screening
University of Illinois Chicago

University of Illinois Chicago researchers will study a new test that screens for 50 types of cancer

Released: 17-Oct-2023 10:05 AM EDT
Wren Laboratories’ NETest leverages mRNA and Artificial Intelligence to create highly accurate, personalized neuroendocrine cancer diagnostics
Wren Laboratories

Blood-based molecular NET cancer test delivers accuracy and specificity levels unsurpassed by other diagnostic methods



close
2.40819